ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis

Breast Cancer trials near Austin, TX, USA:

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Austin, Texas, United States and 62 other locations

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer...

Active, not recruiting
Breast Cancer
Drug: Letrozole
Other: Placebo

Phase 3

National Surgical Adjuvant Breast and Bowel Project Foundation (NSABP)

Austin, Texas, United States and 805 other locations

growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Trastuzumab deruxtecan
Drug: Capecitabine

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 293 other locations

in patients with advanced solid tumors or in combination with anti-cancer agents such as CDK 4/6 inhibitor palbociclib in patients with ER+/ ...

Enrolling
Breast Cancer
Solid Tumor, Adult
Drug: Palbociclib
Drug: APG-2575

Phase 1, Phase 2

Ascentage Pharma Group
Ascentage Pharma Group

Austin, Texas, United States and 3 other locations

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo a...

Active, not recruiting
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Drug: Trilaciclib
Drug: Placebo

Phase 3

G1 Therapeutics

Austin, Texas, United States and 70 other locations

ovarian function in premenopausal women with HR+, HER2-negative breast cancer and men with HR+ breast cancer. The...

Invitation-only
Breast Cancer
Drug: Exemestane Tablets
Drug: Anastrozole Tablets

Phase 3

Tolmar Pharmaceuticals

New Braunfels, Texas, United States and 12 other locations

adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer with intermediate-high or high risk for disease recurren...

Enrolling
Breast Cancer, Early Breast Cancer
Drug: Exemestane
Drug: Letrozole

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 632 other locations

treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and arom...

Enrolling
Breast Cancer
Drug: Alpelisib
Drug: Fulvestrant

Phase 3

Celcuity

Austin, Texas, United States and 217 other locations

receptor-low/HER2-negative breast cancer....

Enrolling
Breast Cancer
Drug: Epirubicin
Drug: Olaparib

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 344 other locations

Locations recently updated

doctor's choice of treatment in people with advanced or metastatic breast cancer. Advanced cancer is the one that is unlik...

Enrolling
Advanced or Metastatic Breast Cancer
Drug: Everolimus
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Round Rock, Texas, United States and 145 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems